Of the 503 stocks in the S&P 500 (some companies have two classes of stocks that are included) fewer than 30% of them, or 148 stocks, beat the index’s average return of…
The incredible returns equity investors have seen in 2024, and over the past couple months for that matter, have been incredible. This period of time really reminds me of the post-pandemic rally…
Live Updates Nasdaq Now Up 1.2% 1:30pm ETEric BleekerAs of 1:30 p.m. ET, the Nasdaq-100 is up 1.25%. That’s significantly outpacing the S&P 500’s .53% gain. The Dow Jones is down very…
If you’re invested in companies like Palantir (Nasdaq: PLTR | PLTR Price Prediction), MicroStrategy (Nasdaq: MSTR), or Axon Enterprises (Nasdaq: AXON), tomorrow is a day that should be circled on your calendar. The Nasdaq-100 is expected to announce a rebalancing…
Investors have been on a roller coaster ride for the past four years and the stock market may be heading into another big loop higher. Federal Reserve chairman Jay Powell gave his…
Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big expectations for Vir Biotechnology.
Invesco QQQ Trust (NASDAQ: QQQ) is an ETF that tracks the performance of the 100 largest companies listed on the Nasdaq. While this is mainly made up of technology companies, it holds…
With the pandemic largely in the rear-view mirror, COVID-19 vaccine winner Novavax has seen shares fall. Yet, analysts have high hopes for the stock.
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital appreciation potential are essential for…
Analysts have been cutting ratings and price targets recently, but here are four stocks that defying the downward pressure.
2018 was one of the last full years we would feel normal as a world for a long time. We had no idea what was hurling around the corner. That year, Drake…
U.S. stocks are adding to Wednesday's comeback with solid gains after about half an hour of trading Thursday morning. Here are winners and losers.
Pfizer stock has tumbled due to shrinking vaccine sales and the potential for a social and consumer backlash. Moderna stock has also been pounded.
Monday's top analyst upgrades and downgrades included Amazon.com, Amgen, Apple, BioCryst Pharmaceuticals, Block, Coinbase Global, Datadog, Fortinet, Gilead Sciences, Intercontinental Exchange, Moderna, Monster Beverage, Nvidia, PayPal and Petrobras.
Friday's top analyst upgrades and downgrades included DXC Technology, Etsy, Extreme Networks, Moderna, PagSeguro Digital, Qualcomm, Roku, Ross Stores, Royal Caribbean Cruises, Southwest Airlines, Spirit AeroSystems, StoneCo and Wayfair.
